On behalf of TMC Life Sciences Berhad (the Company), the Board of Directors announced that the Company has suspended the employment of Puan Wan Nadiah Binti Wan Mohd Abdullah Yaakob as the Group Chief Executive Officer (?GCEO?) of the Company, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from 29 January 2024 until further announcement by the Board. The Board wishes to announce further that the Company will continue its business as usual and during the period of suspension, one of Directors, Dr. Heng Jun Li Melvin, will be appointed as the Acting GCEO, who will temporarily assume the duties and functions of GCEO.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 MYR | -.--% | -4.23% | -4.90% |
May. 24 | TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks | MT |
May. 23 | TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-4.90% | 252M | |
-23.39% | 15.52B | |
-2.70% | 11.8B | |
+2.65% | 11.59B | |
+2.37% | 9.95B | |
+29.48% | 8.62B | |
-10.45% | 7.13B | |
+8.05% | 6.69B | |
-4.29% | 5.71B | |
-3.96% | 4.3B |
- Stock Market
- Equities
- TMCLIFE Stock
- News TMC Life Sciences
- TMC Life Sciences Berhad Announces Suspension of Puan Wan Nadiah Binti Wan Mohd Abdullah Yaakob as Group Chief Executive Officer